ZHX2 enhances the cytotoxicity of chemotherapeutic drugs in liver tumor cells by repressing MDR1 via interfering with NF-YA
Hongxin Ma(Shandong University), Chunhong Ma(Shandong University)
Cited by 39
Related Papers
HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma
|Oncotarget|2015|41
<scp>SREBF2–STARD4</scp> axis confers sorafenib resistance in hepatocellular carcinoma by regulating mitochondrial cholesterol homeostasis
|Cancer Science|2022|36